Evidence map›Paper›PMID 42340098›Full record

ArticleChembiochem : a European journal of chemical biology2026

Quinazolinone and Phthalazinone Inhibitors of the HDAC6/Ubiquitin Protein-Protein Interaction.

Sydney Gordon, Jordi C J Hintzen, Sebastian Dilones, Brockton Keen, Callie E W Crawford, George M Burslem

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Sydney GordonDepartment of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA.
Jordi C J HintzenDepartment of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0002-4621-0711
Sebastian DilonesDepartment of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA.
Brockton KeenDepartment of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA.
Callie E W CrawfordDepartment of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA.
George M BurslemDepartment of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0002-2812-983X

Funding

Editing Acetylation and Protein HomeostasisR35GM142505 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI George Burslem · 2021 to 2026
$2.7M
NIH HHS R35GM142505
6 · The paper itself

Abstract

Histone deacetylase 6 (HDAC6) is a class IIb histone deacetylase that regulates diverse cytosolic acetylation through its two catalytic deacetylase domains and a C-terminal zinc finger ubiquitin-binding domain (ZnF-UBD). This ZnF-UBD mediates key protein-protein interactions (PPIs) that couple deacetylation and ubiquitin-dependent degradation. While most HDAC6 inhibitors target the catalytic domains, the ZnF-UBD represents an underexplored target. Here, we validate previously reported small-molecule inhibitors of the HDAC6 ZnF-UBD/ubiquitin interaction and describe novel N-alkyl moieties based on quinazolinone and phthalazinone scaffolds. Starting from known quinazolinone and phthalazinone scaffolds, a literature and modeling-guided scaffold hop revealed potential for an extended phthalazinone series. Results obtained both in fluorescence polarization (FP) and differential scanning fluorimetry (DSF) confirm this hypothesis. Additionally, late-stage diversification yields compounds with improved predicted physicochemical properties. Finally, machine-learning-based co-folding affinity predictions correlate with experimental IC

Indexed as

Histone Deacetylase 6Histone Deacetylase InhibitorsPhthalazinesQuinazolinonesUbiquitinHumansProtein BindingZinc FingersHDAC6 protein, humanHistone Deacetylase 6Histone Deacetylase InhibitorsPhthalazinesQuinazolinonesUbiquitinHDAC6PPI inhibitorprotein–protein interactionszinc finger ubiquitin binding

Identifiers

PMID42340098
PMCPMC13292185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.